D
Celldex Therapeutics, Inc. CLDX
$21.75 -$0.18-0.82% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -5.21% -14.24% -11.80% -17.52% -9.25%
Total Depreciation and Amortization 0.69% 5.86% 4.20% -1.38% 2.84%
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 6.41% 9.84% 21.36% 82.45% -25.58%
Change in Net Operating Assets 149.64% -215.18% 138.23% -784.63% 122.54%
Cash from Operations 19.07% -67.42% 41.31% -88.69% 27.83%
Capital Expenditure -174.72% 64.95% -38.72% -98.91% 20.35%
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 17.04% 74.23% -48.65% 203.99% 85.25%
Cash from Investing 16.07% 78.61% -49.65% 202.22% 85.18%
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock -68.81% -47.67% -68.85% -66.62% -99.15%
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- -- -- --
Cash from Financing -68.81% -47.67% -68.85% -66.62% -99.15%
Foreign Exchange rate Adjustments -- -- -- -- --
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 152.66% -39.50% -26.86% 91.24% -190.13%